Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Shenzhen Salubris Pharmaceuticals Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥400.70 Million ≈ $58.63 Million USD) by net assets (CN¥8.93 Billion ≈ $1.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

Cash flow conversion efficiency of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. This chart illustrates how Shenzhen Salubris Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shenzhen Salubris Pharmaceuticals Co Ltd (002294) stock price for real-time trading data and today's change.

Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Conversion Ratio Explained

Shenzhen Salubris Pharmaceuticals Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shenzhen Salubris Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Salubris Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Also see Shenzhen Salubris Pharmaceuticals Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CCC Intelligent Solutions Holdings Inc. Common Stock NASDAQ:CCCS	0.021x
Zalando SE XETRA:ZAL	-0.162x
Bank of Ayudhya Public Company Limited F:NVAU	0.070x
Murphy Oil Corporation NYSE:MUR	0.061x
Vail Resorts Inc NYSE:MTN	0.675x
Landstar System Inc NASDAQ:LSTR	-0.060x
Eagle Materials Inc NYSE:EXP	0.104x
CSW Industrials Inc NASDAQ:CSWI	0.025x

Annual Cash Flow Conversion Efficiency for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. Review how much free cash does Shenzhen Salubris Pharmaceuticals Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.75 Billion ≈ $1.28 Billion	CN¥1.19 Billion ≈ $173.59 Million	0.136x	+25.52%
2023-12-31	CN¥8.06 Billion ≈ $1.18 Billion	CN¥869.79 Million ≈ $127.28 Million	0.108x	-11.28%
2022-12-31	CN¥7.98 Billion ≈ $1.17 Billion	CN¥970.80 Million ≈ $142.06 Million	0.122x	-17.36%
2021-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥1.18 Billion ≈ $173.40 Million	0.147x	-40.08%
2020-12-31	CN¥5.59 Billion ≈ $818.24 Million	CN¥1.37 Billion ≈ $201.11 Million	0.246x	+8.75%
2019-12-31	CN¥6.67 Billion ≈ $975.50 Million	CN¥1.51 Billion ≈ $220.47 Million	0.226x	+15.83%
2018-12-31	CN¥6.87 Billion ≈ $1.01 Billion	CN¥1.34 Billion ≈ $196.18 Million	0.195x	-17.57%
2017-12-31	CN¥6.16 Billion ≈ $901.18 Million	CN¥1.46 Billion ≈ $213.31 Million	0.237x	-9.93%
2016-12-31	CN¥5.46 Billion ≈ $798.98 Million	CN¥1.43 Billion ≈ $209.96 Million	0.263x	+16.85%
2015-12-31	CN¥4.70 Billion ≈ $687.12 Million	CN¥1.06 Billion ≈ $154.53 Million	0.225x	-13.27%
2014-12-31	CN¥3.79 Billion ≈ $554.32 Million	CN¥982.25 Million ≈ $143.73 Million	0.259x	+21.59%
2013-12-31	CN¥3.13 Billion ≈ $458.73 Million	CN¥668.52 Million ≈ $97.83 Million	0.213x	+6.65%
2012-12-31	CN¥2.61 Billion ≈ $381.44 Million	CN¥521.21 Million ≈ $76.27 Million	0.200x	+56.74%
2011-12-31	CN¥2.13 Billion ≈ $312.36 Million	CN¥272.32 Million ≈ $39.85 Million	0.128x	+27.50%
2010-12-31	CN¥1.87 Billion ≈ $272.96 Million	CN¥186.65 Million ≈ $27.31 Million	0.100x	+20.96%
2009-12-31	CN¥1.62 Billion ≈ $237.55 Million	CN¥134.28 Million ≈ $19.65 Million	0.083x	-72.08%
2008-12-31	CN¥262.90 Million ≈ $38.47 Million	CN¥77.89 Million ≈ $11.40 Million	0.296x	-18.02%
2007-12-31	CN¥145.96 Million ≈ $21.36 Million	CN¥52.75 Million ≈ $7.72 Million	0.361x	+220.57%
2006-12-31	CN¥106.48 Million ≈ $15.58 Million	CN¥12.00 Million ≈ $1.76 Million	0.113x	--

About Shenzhen Salubris Pharmaceuticals Co Ltd

SHE:002294 China Drug Manufacturers - Specialty & Generic

Market Cap

$5.14 Billion

CN¥35.12 Billion CNY

Market Cap Rank

#3422 Global

#431 in China

Share Price

CN¥31.50

Change (1 day)

+2.81%

52-Week Range

CN¥29.60 - CN¥68.30

All Time High

CN¥68.30